Cancer BiologybioRxivPreprint
Epigenetic and 3D Genome Changes Drive Primary Trastuzumab Resistance in HER2+ Breast Cancer
Ningjun Duan, Yijia Hua, Zhengxing Zhou…·Yongmei Yin
This study identifies epigenetic and 3D genome changes as key drivers of primary trastuzumab resistance in HER2+ breast cancer through integrative analysis of chromatin architecture and histone modifications.